Jeevan Scientific Technology Ltd — Important, 18-12-2025: Company Update

Jeevan Scientific Technology Limited provided an update on its acquisition of Naya Pharma Private Limited. The company previously approved the issue of 35,00,000 convertible warrants and 41,85,000 equity shares. An amount of 10.00 Cr from these proceeds will fund the acquisition of M/s. Naya Pharma Private Limited. This move will secure 60% control of Naya Pharma, diversifying Jeevan Scientific's business into the pharma sector and creating synergy with its existing clinical trials operations. Naya Pharma, with a paid-up capital of approximately 3.67 Cr, specializes in Active Pharmaceutical Ingredients and bulk drugs. The acquisition involves related parties.